These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33844493)

  • 21. Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.
    Janowsky A; Tosh DK; Eshleman AJ; Jacobson KA
    J Pharmacol Exp Ther; 2016 Apr; 357(1):24-35. PubMed ID: 26813929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and preliminary SAR study of 3- and 6-side-chain-extended tetrahydro-pyran analogues of cis- and trans-(6-benzhydryl-tetrahydropyran-3-yl)-benzylamine.
    Zhang S; Zhen J; Reith ME; Dutta AK
    Bioorg Med Chem; 2006 Jun; 14(11):3953-66. PubMed ID: 16481172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
    Siebert GA; Pond SM; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative modeling of the human monoamine transporters: similarities in substrate binding.
    Koldsø H; Christiansen AB; Sinning S; Schiøtt B
    ACS Chem Neurosci; 2013 Feb; 4(2):295-309. PubMed ID: 23421681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
    Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
    Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
    Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
    Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
    J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Functional Evaluation of 1, 5-Disubstituted Tetrazoles as Monoamine Neurotransmitter Reuptake Inhibitors.
    Paudel S; Wang S; Kim E; Kundu D; Min X; Shin CY; Kim KM
    Biomol Ther (Seoul); 2022 Mar; 30(2):191-202. PubMed ID: 34789584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an exocyclic hydroxyl group: interaction with dopamine, serotonin, and norepinephrine transporters.
    Mishra M; Kolhatkar R; Zhen J; Parrington I; Reith ME; Dutta AK
    Bioorg Med Chem; 2008 Mar; 16(6):2769-78. PubMed ID: 18249549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
    Shen F; Tsuruda PR; Smith JA; Obedencio GP; Martin WJ
    PLoS One; 2013; 8(9):e74891. PubMed ID: 24098676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats.
    Dutta AK; Santra S; Harutyunyan A; Das B; Lisieski MJ; Xu L; Antonio T; Reith MEA; Perrine SA
    Eur J Pharmacol; 2019 Nov; 862():172632. PubMed ID: 31473161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
    Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.
    Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
    Bioorg Med Chem; 2017 Oct; 25(20):5278-5289. PubMed ID: 28807575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration.
    Ortore G; Orlandini E; Betti L; Giannaccini G; Mazzoni MR; Camodeca C; Nencetti S
    ACS Chem Neurosci; 2020 Oct; 11(20):3214-3232. PubMed ID: 32991141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.
    Madras BK; Xie Z; Lin Z; Jassen A; Panas H; Lynch L; Johnson R; Livni E; Spencer TJ; Bonab AA; Miller GM; Fischman AJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):561-9. PubMed ID: 16885432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.
    Zhang P; Cyriac G; Kopajtic T; Zhao Y; Javitch JA; Katz JL; Newman AH
    J Med Chem; 2010 Aug; 53(16):6112-21. PubMed ID: 20672825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters.
    Tsuruda PR; Yung J; Martin WJ; Chang R; Mai N; Smith JA
    J Pharmacol Toxicol Methods; 2010; 61(2):192-204. PubMed ID: 20036748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.